On site training: Risk Management 360°: Where ISO 14971 Meets the New ISO 10993-1

Event Date(s) :
09:30 Wednesday, Dec 16, 2026 - 17:00 Wednesday, Dec 16, 2026
Tags :
Italy
Milan
Risk assessment

Abstract

This course provides a comprehensive overview of medical device risk management under the EU MDR, EN ISO 14971:2019/A11:2021, and the new ISO 10993-1:2025. Participants will learn how to establish, implement, maintain, and document an integrated risk management process throughout the entire medical device lifecycle, while ensuring consistency between general risk management and biological risk evaluation. The training focuses on the practical application of regulatory requirements, risk analysis methodologies, risk control strategies, and documentation expectations from Notified Bodies. Special attention will be given to the integration of ISO 14971 and ISO 10993-1:2025 requirements, enabling participants to develop a coherent and effective risk management framework that supports compliance, product safety, and successful certification activities.

Participants will be eligible to request a complimentary 30-minute consultation with our experts.

At the end of the course, participants will receive the course slides and a Certificate of Competence.

 

Location and Language

  • Location: Eurofins Biolab, Via Bruno Buozzi 2, 20055 Vimodrone (MI), Italy
  • Language: Italian

Key Topics

Module I: Medical Device Risk Management Fundamentals

  • MDR safety and performance requirements related to risk management
  • Overview of EN ISO 14971:2019/A11:2021
  • Risk Management Plan development
  • Intended purpose and reasonably foreseeable misuse
  • Identification of hazards and hazardous situations
  • Risk estimation, evaluation, and acceptability criteria
  • Risk control measures and mitigation strategies
  • Residual risk evaluation and benefit-risk assessment
  • Risk management review and lifecycle approach
  • Collection and evaluation of production and post-market information
  • Risk Management Report preparation
  • Notified Body expectations, common findings, and non-conformities

Module II: Integrating ISO 14971 and ISO 10993-1:2025

  • Key updates introduced by ISO 10993-1:2025
  • Impact of the new standard on the overall risk management process
  • Integration of biological risk assessment within the ISO 14971 framework
  • Harmonizing risk management and biological evaluation documentation
  • Interrelationships between:Risk Management
  • Biological Evaluation
  • Preclinical Assessment
  • Usability Engineering
  • Clinical Evaluation
  • Post-Market Surveillance
  • Labelling and Risk Communication
  • Building a consistent documentation package for regulatory submissions and Notified Bodies

Who Should Join?

This course is intended for medical device manufacturers, Quality Management System (QMS) professionals, Quality Assurance personnel, Regulatory Affairs specialists, Research & Development teams, consultants, and all professionals involved in planning, implementing, and maintaining medical device risk management activities throughout the product lifecycle.

A basic knowledge of ISO 10993-1:2025 and the EU MDR is recommended.

Speaker

  • Margherita Miccheli, Team Leader Medical Devices Consultant Eurofins Regulatory & Consultancy Services

Registration Fees

€750 + VAT

10% discount for registrations completed by 30 July 2026
5% discount for registrations completed by 30 August 2026
10% discount on the second registration from the same company

Click here to register